Women's Health 2024: Beyond the Annual Visit - East - October 25, 2024

The quality of healthcare provided to women has never been more relevant. That’s why there’s Women’s Health 2024: Beyond the Annual Visit. Join us!

Live Broadcast
6.00 available credits
Information
October 25, 2024
08:00 AM - 04:00 PM EDT
ReachMD Healthcare Image

This live broadcast will start in exactly:

  • 0

    Day(s)

  • 0

    Hour(s)

  • 0

    Minute(s)

  • 0

    Second(s)

Details
Presenters
Comments
  • Overview

    We're excited to announce Dr. Anita Nelson, Dr. Amy Clouse, and Ms. Barbara Dehn as this year's Planning Committee and Moderators!

    Join the conversation #WH24

    Please see below for when the Live Broadcast will begin in your time zone:

    • 7 AM CT
    • 8 AM ET
    • 6 AM MT
    • 5 AM PT
  • Program Schedule

    Coming Soon! Topics may include:

    • Cardiovascular Disease in Women
    • Cervical Cancer Screening
    • Contraception
    • Female Sexual Dysfunction/Hypoactive Sexual Desire Disorder (HSDD)
    • Fertility/Infertility
    • GLPs in Women’s Health/Obesity
    • Hemolytic Disease of the Fetus and Newborn (HDFN)
    • Iron-Deficiency Anemia
    • Major Depressive Disorder (MDD)
    • Menopause and Vasomotor Symptoms
    • Migraine
    • Narcolepsy and Sleep Disorders
    • Osteoporosis
    • Overcoming Healthcare Disparities
    • PCOS
    • Postpartum Depression
    • Sexually Transmitted Infections (STI)
    • Sleep Apnea
    • Uterine Fibroids (UF)/Endometriosis
    • Vulvovaginal Candidiasis (VVC)
  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Planning Committee:

    Amy Clouse, MD
    Associate Clinical Professor
    Sidney Kimmel Medical College, Thomas Jefferson University
    Associate Residency Director, Family Medicine Residency Program
    Jefferson – Abington Health
    Jenkintown, PA 

    Dr. Clouse has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Astellas

    Barbara Dehn, WHNP-BC
    Nurse Practitioner
    Planned Parenthood
    Albany, NY

    Barbara Dehn has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Acella, Avion, Bonafide, Pharmavite, Shield Therapeutics
    Vendor: Cord Blood Registry

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology, UCLA
    Los Angeles, CA

    Dr. Nelson has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Bayer, Exeltis USA, Inc, Merck, Myovant, Sumitomo Pharma America, Inc
    Contracted Research: Daré Bioscience,Mylan Pharmaceuticals, Organon & Co, Sebela Pharmaceuticals, Sumitomo Pharma America, Viatris Pharmaceuticals, Inc 

    Faculty:

    Coming Soon!

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Barry Fiedel, PhD, has nothing to disclose.
    • Tim Person has nothing to disclose.
  • Target Audience

    This activity has been designed to meet the educational needs of ob-gyns and ob-gyn advanced practice nurses and physician assistants, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare professionals who manage the health needs of women.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.0 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6 contact hours/.6 CEUs of pharmacy contact hours.

    The Universal Activity Number for this program is JA0006235-0000-24-103-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Details
Presenters
Comments
  • Overview

    We're excited to announce Dr. Anita Nelson, Dr. Amy Clouse, and Ms. Barbara Dehn as this year's Planning Committee and Moderators!

    Join the conversation #WH24

    Please see below for when the Live Broadcast will begin in your time zone:

    • 7 AM CT
    • 8 AM ET
    • 6 AM MT
    • 5 AM PT
  • Program Schedule

    Coming Soon! Topics may include:

    • Cardiovascular Disease in Women
    • Cervical Cancer Screening
    • Contraception
    • Female Sexual Dysfunction/Hypoactive Sexual Desire Disorder (HSDD)
    • Fertility/Infertility
    • GLPs in Women’s Health/Obesity
    • Hemolytic Disease of the Fetus and Newborn (HDFN)
    • Iron-Deficiency Anemia
    • Major Depressive Disorder (MDD)
    • Menopause and Vasomotor Symptoms
    • Migraine
    • Narcolepsy and Sleep Disorders
    • Osteoporosis
    • Overcoming Healthcare Disparities
    • PCOS
    • Postpartum Depression
    • Sexually Transmitted Infections (STI)
    • Sleep Apnea
    • Uterine Fibroids (UF)/Endometriosis
    • Vulvovaginal Candidiasis (VVC)
  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Planning Committee:

    Amy Clouse, MD
    Associate Clinical Professor
    Sidney Kimmel Medical College, Thomas Jefferson University
    Associate Residency Director, Family Medicine Residency Program
    Jefferson – Abington Health
    Jenkintown, PA 

    Dr. Clouse has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Astellas

    Barbara Dehn, WHNP-BC
    Nurse Practitioner
    Planned Parenthood
    Albany, NY

    Barbara Dehn has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Acella, Avion, Bonafide, Pharmavite, Shield Therapeutics
    Vendor: Cord Blood Registry

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology, UCLA
    Los Angeles, CA

    Dr. Nelson has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Bayer, Exeltis USA, Inc, Merck, Myovant, Sumitomo Pharma America, Inc
    Contracted Research: Daré Bioscience,Mylan Pharmaceuticals, Organon & Co, Sebela Pharmaceuticals, Sumitomo Pharma America, Viatris Pharmaceuticals, Inc 

    Faculty:

    Coming Soon!

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Barry Fiedel, PhD, has nothing to disclose.
    • Tim Person has nothing to disclose.
  • Target Audience

    This activity has been designed to meet the educational needs of ob-gyns and ob-gyn advanced practice nurses and physician assistants, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare professionals who manage the health needs of women.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.0 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6 contact hours/.6 CEUs of pharmacy contact hours.

    The Universal Activity Number for this program is JA0006235-0000-24-103-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Register

We're glad to see you're enjoying Omnia Education…
but how about a more personalized experience?

Register for free